These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 20813466)
1. Effect of hyperoxygenation on tissue pO2 and its effect on radiotherapeutic efficacy of orthotopic F98 gliomas. Khan N; Mupparaju S; Hekmatyar SK; Hou H; Lariviere JP; Demidenko E; Gladstone DJ; Kauppinen RA; Swartz HM Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1193-200. PubMed ID: 20813466 [TBL] [Abstract][Full Text] [Related]
2. Tissue pO2 of orthotopic 9L and C6 gliomas and tumor-specific response to radiotherapy and hyperoxygenation. Khan N; Li H; Hou H; Lariviere JP; Gladstone DJ; Demidenko E; Swartz HM Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):878-85. PubMed ID: 19136221 [TBL] [Abstract][Full Text] [Related]
3. Synergistic combination of hyperoxygenation and radiotherapy by repeated assessments of tumor pO2 with EPR oximetry. Hou H; Dong R; Lariviere JP; Mupparaju SP; Swartz HM; Khan N J Radiat Res; 2011; 52(5):568-74. PubMed ID: 21799293 [TBL] [Abstract][Full Text] [Related]
4. Dynamic changes in oxygenation of intracranial tumor and contralateral brain during tumor growth and carbogen breathing: a multisite EPR oximetry with implantable resonators. Hou H; Dong R; Li H; Williams B; Lariviere JP; Hekmatyar SK; Kauppinen RA; Khan N; Swartz H J Magn Reson; 2012 Jan; 214(1):22-8. PubMed ID: 22033225 [TBL] [Abstract][Full Text] [Related]
5. Repeated assessment of orthotopic glioma pO(2) by multi-site EPR oximetry: a technique with the potential to guide therapeutic optimization by repeated measurements of oxygen. Khan N; Mupparaju S; Hou H; Williams BB; Swartz H J Neurosci Methods; 2012 Feb; 204(1):111-117. PubMed ID: 22079559 [TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle and glioma oxygenation by carbogen inhalation in rats: a longitudinal study by EPR oximetry using single-probe implantable oxygen sensors. Hou H; Khan N; Lariviere J; Hodge S; Chen EY; Jarvis LA; Eastman A; Williams BB; Kuppusamy P; Swartz HM Adv Exp Med Biol; 2014; 812():97-103. PubMed ID: 24729220 [TBL] [Abstract][Full Text] [Related]
7. Potential role of hypoxia imaging using (18)F-FAZA PET to guide hypoxia-driven interventions (carbogen breathing or dose escalation) in radiation therapy. Tran LB; Bol A; Labar D; Karroum O; Bol V; Jordan B; Grégoire V; Gallez B Radiother Oncol; 2014 Nov; 113(2):204-9. PubMed ID: 25434767 [TBL] [Abstract][Full Text] [Related]
8. In vivo measurement of regional oxygenation and imaging of redox status in RIF-1 murine tumor: effect of carbogen-breathing. Ilangovan G; Li H; Zweier JL; Krishna MC; Mitchell JB; Kuppusamy P Magn Reson Med; 2002 Oct; 48(4):723-30. PubMed ID: 12353291 [TBL] [Abstract][Full Text] [Related]
9. Monitoring oxygen levels in orthotopic human glioma xenograft following carbogen inhalation and chemotherapy by implantable resonator-based oximetry. Hou H; Krishnamurthy Nemani V; Du G; Montano R; Song R; Gimi B; Swartz HM; Eastman A; Khan N Int J Cancer; 2015 Apr; 136(7):1688-96. PubMed ID: 25111969 [TBL] [Abstract][Full Text] [Related]
10. Changes in oxygenation of intracranial tumors with carbogen: a BOLD MRI and EPR oximetry study. Dunn JF; O'Hara JA; Zaim-Wadghiri Y; Lei H; Meyerand ME; Grinberg OY; Hou H; Hoopes PJ; Demidenko E; Swartz HM J Magn Reson Imaging; 2002 Nov; 16(5):511-21. PubMed ID: 12412027 [TBL] [Abstract][Full Text] [Related]
11. Repeated tumor pO(2) measurements by multi-site EPR oximetry as a prognostic marker for enhanced therapeutic efficacy of fractionated radiotherapy. Hou H; Lariviere JP; Demidenko E; Gladstone D; Swartz H; Khan N Radiother Oncol; 2009 Apr; 91(1):126-31. PubMed ID: 19013657 [TBL] [Abstract][Full Text] [Related]
12. Modulation of tumor hypoxia by topical formulations with vasodilators for enhancing therapy. Abramovic Z; Hou H; Julijana K; Sentjurc M; Lariviere JP; Swartz HM; Khan N Adv Exp Med Biol; 2011; 701():75-82. PubMed ID: 21445772 [TBL] [Abstract][Full Text] [Related]
13. Changes in tumor oxygenation/perfusion induced by the no donor, isosorbide dinitrate, in comparison with carbogen: monitoring by EPR and MRI. Jordan BF; Misson P; Demeure R; Baudelet C; Beghein N; Gallez B Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):565-70. PubMed ID: 10974477 [TBL] [Abstract][Full Text] [Related]
14. Measurement of differences in pO2 in response to perfluorocarbon/carbogen in FSa and NFSa murine fibrosarcomas with low-frequency electron paramagnetic resonance oximetry. Halpern HJ; Yu C; Peric M; Barth ED; Karczmar GS; River JN; Grdina DJ; Teicher BA Radiat Res; 1996 May; 145(5):610-8. PubMed ID: 8619027 [TBL] [Abstract][Full Text] [Related]
15. Effect of RSR13, an allosteric hemoglobin modifier, on oxygenation in murine tumors: an in vivo electron paramagnetic resonance oximetry and bold MRI study. Hou H; Khan N; O'Hara JA; Grinberg OY; Dunn JF; Abajian MA; Wilmot CM; Makki M; Demidenko E; Lu S; Steffen RP; Swartz HM Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):834-43. PubMed ID: 15183487 [TBL] [Abstract][Full Text] [Related]
16. Assessment of the changes in 9L and C6 glioma pO2 by EPR oximetry as a prognostic indicator of differential response to radiotherapy. Hou H; Mupparaju SP; Lariviere JP; Hodge S; Gui J; Swartz HM; Khan N Radiat Res; 2013 Mar; 179(3):343-51. PubMed ID: 23391148 [TBL] [Abstract][Full Text] [Related]
17. In vivo determination of tumor oxygenation during growth and in response to carbogen breathing using 15C5-loaded alginate capsules as fluorine-19 magnetic resonance imaging oxygen sensors. Nöth U; Rodrigues LM; Robinson SP; Jork A; Zimmermann U; Newell B; Griffiths JR Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):909-19. PubMed ID: 15465209 [TBL] [Abstract][Full Text] [Related]
18. Temporal variation in the response of tumors to hyperoxia with breathing carbogen and oxygen. Hou HG; Khan N; Du GX; Hodge S; Swartz HM Med Gas Res; 2016; 6(3):138-146. PubMed ID: 27867481 [TBL] [Abstract][Full Text] [Related]
19. Variability in blood flow and pO2 in tumors in response to carbogen breathing. Lanzen JL; Braun RD; Ong AL; Dewhirst MW Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):855-9. PubMed ID: 9845110 [TBL] [Abstract][Full Text] [Related]
20. Tumor R2* is a prognostic indicator of acute radiotherapeutic response in rodent tumors. Rodrigues LM; Howe FA; Griffiths JR; Robinson SP J Magn Reson Imaging; 2004 Apr; 19(4):482-8. PubMed ID: 15065173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]